Dr. Andrew Rut, CEO of MyMeds&Me is delighted to be chairing and speaking at a key session at the World Drug Safety Congress Europe (WDSC) 10–11 September 2018, in Amsterdam. The conference will unite senior level drug safety professionals and include stakeholders from pharma and biotechs to regulators and patients.
This year the conference focuses on how to manage the increasingly diverse data sources both effectively and efficiently. Panel discussions during the two-day event will include the exploration of AI in pharmacovigilance, risk-based approaches to signal management and the challenges faced by emerging markets.
Dr. Rut will be chairing a session on case processing on Tuesday 11 September at 15:15, which will include talks on automation and AI in case processing, and changes and challenges in EurdraVigilance systems. Dr Rut will also be speaking at the 15:40 session about ‘How structured intake can maximise efficiencies through case processing.’
Dr. Rut said ‘I am delighted to be participating in the World Drug Safety Congress as it represents an excellent opportunity to discuss the major issues and trends in pharmacovigilance and share best practice with colleagues from across the world.'
‘A key topic for discussion will be the importance of capturing data at source and right first time to enable downstream process efficiency combined with enhanced signal management on a higher quality dataset. New technologies are providing the opportunity to obtain quality data at the source of the data collection process and to collate this in a structured way, which ensures the information is relevant, secure, coded and rapidly available. A standardised capture of data in a coded structure minimises the chances of the data becoming corrupted by the interim processing steps and improves efficiencies.’
Dr. Andrew Rut is in frequent attendance at conferences around patient safety and regulation; he spoke most recently at Pvlegal in July 2018. Prior to this, Dr. Rut spoke at FutureLink 2018 in Munich, Germany 5-7 June about transforming adverse event reporting and patient safety with serialised medicine.
